Alexion Pharmaceuticals, Inc. ALXN

Alexion Pharmaceuticals, Inc. DPO Ratio 2011-2026 | ALXN

Annual DPO Ratio Alexion Pharmaceuticals, Inc.

2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
78.2	68.5	72.6	56.9	90.5	89.8	92.4	44.4	108	62.8

All numbers in USD currency

Maximum	Minimum	Average
108	44.4	76.4

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain
Celldex Therapeutics CLDX	4.06 K	$ 34.55	2.04 %	$ 2.29 B	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Alnylam Pharmaceuticals ALNY	55	$ 309.66	-3.27 %	$ 40.6 B	USA
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Amphastar Pharmaceuticals AMPH	31.7	$ 22.88	4.91 %	$ 1.07 B	USA
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
BioXcel Therapeutics BTAI	34.2 K	$ 1.15	7.48 %	$ 14 M	USA
Akebia Therapeutics AKBA	168	$ 1.41	4.07 %	$ 363 M	USA
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
Aquestive Therapeutics AQST	395	$ 4.32	1.41 %	$ 462 M	USA
Arcutis Biotherapeutics ARQT	133	$ 24.53	1.41 %	$ 3.12 B	USA
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	96.3	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	9.57	$ 1.6	-0.62 %	$ 426 M	Britain
BeiGene, Ltd. BGNE	915	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	182	-	-	$ 546 M	USA